Cargando…
Determining SARS-CoV-2 non-infectivity state–A brief overview
From the beginning of the COVID-19 pandemic, it has claimed over 6 million lives, and globally the pandemic rages with detrimental consequences, with the emergence of new more infectious and possibly virulent variants. A clinical obstacle in this battle has been to determine when an infected individ...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412020/ https://www.ncbi.nlm.nih.gov/pubmed/36033758 http://dx.doi.org/10.3389/fpubh.2022.934242 |
_version_ | 1784775397896880128 |
---|---|
author | Brynjolfsson, Siggeir F. Sigurgrimsdottir, Hildur Gudlaugsson, Olafur Kristjansson, Mar Kristinsson, Karl G. Ludviksson, Bjorn R. |
author_facet | Brynjolfsson, Siggeir F. Sigurgrimsdottir, Hildur Gudlaugsson, Olafur Kristjansson, Mar Kristinsson, Karl G. Ludviksson, Bjorn R. |
author_sort | Brynjolfsson, Siggeir F. |
collection | PubMed |
description | From the beginning of the COVID-19 pandemic, it has claimed over 6 million lives, and globally the pandemic rages with detrimental consequences, with the emergence of new more infectious and possibly virulent variants. A clinical obstacle in this battle has been to determine when an infected individual has reached a non-infectious state. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) can be transmitted under diverse circumstances, and various rules and regulations, along with different testing methods, have been applied in an attempt to confine the transmission. However, that has proven to be a difficult task. In this review, we take together recently published data on infectivity and transmission of SARS-CoV-2 and have combined it with the clinical experience that physicians in Iceland have accumulated from the pandemic. In addition, we suggest guidelines for determining when patients with COVID-19 reach a non-infectious state based on a combination of clinical experience, scientific data, and proficient use of available tests. This review has addressed some of the questions regarding contagiousness and immunity against SARS-CoV-2. |
format | Online Article Text |
id | pubmed-9412020 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94120202022-08-27 Determining SARS-CoV-2 non-infectivity state–A brief overview Brynjolfsson, Siggeir F. Sigurgrimsdottir, Hildur Gudlaugsson, Olafur Kristjansson, Mar Kristinsson, Karl G. Ludviksson, Bjorn R. Front Public Health Public Health From the beginning of the COVID-19 pandemic, it has claimed over 6 million lives, and globally the pandemic rages with detrimental consequences, with the emergence of new more infectious and possibly virulent variants. A clinical obstacle in this battle has been to determine when an infected individual has reached a non-infectious state. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) can be transmitted under diverse circumstances, and various rules and regulations, along with different testing methods, have been applied in an attempt to confine the transmission. However, that has proven to be a difficult task. In this review, we take together recently published data on infectivity and transmission of SARS-CoV-2 and have combined it with the clinical experience that physicians in Iceland have accumulated from the pandemic. In addition, we suggest guidelines for determining when patients with COVID-19 reach a non-infectious state based on a combination of clinical experience, scientific data, and proficient use of available tests. This review has addressed some of the questions regarding contagiousness and immunity against SARS-CoV-2. Frontiers Media S.A. 2022-08-12 /pmc/articles/PMC9412020/ /pubmed/36033758 http://dx.doi.org/10.3389/fpubh.2022.934242 Text en Copyright © 2022 Brynjolfsson, Sigurgrimsdottir, Gudlaugsson, Kristjansson, Kristinsson and Ludviksson. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Brynjolfsson, Siggeir F. Sigurgrimsdottir, Hildur Gudlaugsson, Olafur Kristjansson, Mar Kristinsson, Karl G. Ludviksson, Bjorn R. Determining SARS-CoV-2 non-infectivity state–A brief overview |
title | Determining SARS-CoV-2 non-infectivity state–A brief overview |
title_full | Determining SARS-CoV-2 non-infectivity state–A brief overview |
title_fullStr | Determining SARS-CoV-2 non-infectivity state–A brief overview |
title_full_unstemmed | Determining SARS-CoV-2 non-infectivity state–A brief overview |
title_short | Determining SARS-CoV-2 non-infectivity state–A brief overview |
title_sort | determining sars-cov-2 non-infectivity state–a brief overview |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412020/ https://www.ncbi.nlm.nih.gov/pubmed/36033758 http://dx.doi.org/10.3389/fpubh.2022.934242 |
work_keys_str_mv | AT brynjolfssonsiggeirf determiningsarscov2noninfectivitystateabriefoverview AT sigurgrimsdottirhildur determiningsarscov2noninfectivitystateabriefoverview AT gudlaugssonolafur determiningsarscov2noninfectivitystateabriefoverview AT kristjanssonmar determiningsarscov2noninfectivitystateabriefoverview AT kristinssonkarlg determiningsarscov2noninfectivitystateabriefoverview AT ludvikssonbjornr determiningsarscov2noninfectivitystateabriefoverview |